|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.000 USD | +3.52% |
|
+8.93% | -8.56% |
| 05-12 | Bolt Biotherapeutics reports first quarter 2026 financial results | RE |
| 05-12 | Bolt Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.52% | +8.93% | +5.49% | +1.01% | -8.56% | -28.57% | -86.11% | -98.67% | - | 9.61M | |
| +0.12% | +3.61% | -2.11% | -0.40% | -3.04% | +43.06% | +85.19% | +207.25% | +5,954.01% | 50.39B | |
| -5.43% | -7.43% | -3.32% | +1.08% | +13.65% | +68.79% | +55.56% | -19.31% | - | 46.03B | |
| -2.01% | +10.11% | -24.63% | -22.27% | -33.57% | +76.22% | +517.30% | +340.79% | +971.55% | 25.06B | |
| -0.26% | -1.11% | -6.52% | -13.11% | -3.37% | -0.10% | -12.59% | -52.28% | - | 23.26B | |
| +3.19% | +3.12% | -8.97% | -16.84% | +7.12% | +41.22% | -27.18% | -68.79% | - | 17.24B | |
| -1.66% | -4.24% | -8.63% | -11.58% | -16.92% | +29.99% | -41.30% | -24.52% | +66.90% | 16.15B | |
| -2.91% | -10.30% | -18.45% | +14.26% | +6.37% | +47.85% | +186.19% | +123.63% | - | 14.56B | |
| -3.46% | +5.77% | -13.00% | +21.26% | +3.72% | -20.26% | +954.65% | +235.30% | +118.55% | 14.08B | |
| +0.41% | -2.37% | -15.88% | +5.82% | +11.32% | +40.93% | - | - | - | 12.94B | |
| -0.37% | +10.58% | +11.43% | +16.35% | +16.59% | +14.45% | +166.42% | +99.92% | +810.87% | 12.84B | |
| +4.05% | +0.94% | +2.84% | +16.18% | -7.29% | +90.87% | +84.31% | +300.81% | - | 12.45B | |
| +2.32% | +2.23% | +19.49% | +24.87% | +20.03% | +434.47% | +102.67% | +9.42% | +1,423.71% | 11.22B | |
| +3.22% | +3.94% | +16.38% | +16.54% | +21.53% | +157.40% | +105.15% | +197.80% | +929.60% | 9.79B | |
| 0.00% | +18.66% | +21.81% | +7.86% | +66.38% | +70.83% | +151.90% | +1,041.85% | +438.34% | 9.2B | |
| -0.67% | -8.55% | -24.47% | +10.65% | +24.10% | +116.87% | +123.10% | -6.14% | - | 8.42B | |
| 0.00% | +5.03% | +7.24% | +37.09% | +311.62% | +227.31% | +257.46% | -46.13% | - | 8.54B | |
| +4.36% | +0.19% | -2.41% | -12.60% | -29.07% | - | - | - | - | 8.79B | |
| -0.77% | +1.96% | -0.58% | +3.56% | +3.80% | +47.01% | +165.00% | - | - | 8.25B | |
| +0.74% | -.--% | -.--% | -.--% | -.--% | -.--% | +40.81% | +230.59% | - | 8.19B | |
| Average | +0.19% | +1.15% | -2.22% | +4.99% | +20.22% | +76.75% | +157.14% | +145.38% | +1,339.19% | 15.87B | |
| Weighted average by Cap. | -0.72% | +0.77% | -4.37% | +1.64% | +11.04% | +68.29% | +156.35% | +133.97% | +2,465.07% |
- Stock Market
- Equities
- BOLT Stock
- Sector Bolt Biotherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition